Abstract
Gastroesophageal reflux disease (GERD) is a common comorbidity in the obese population. Prevalence in the obese population is estimated to be around 37-72%. Therefore, GERD may be preexisting or may occur de novo after a bariatric operation. GERD results from a failure of normal anti-reflux barriers, centered around the esophagus, lower esophageal sphincter (LES), the crural portion of the hiatus, and the stomach. The pathophysiology behind obesity-related GERD appears to be the result of a multitude of anatomic and physiologic changes at the LES imposed by the central and visceral adiposity of obesity. Fundoplication has been considered the gold standard for surgical treatment of reflux disease. Beyond RYGB, laparoscopic sleeve gastrectomy (SG) has become the most popular primary bariatric operation, but not in the treatment of GERD. While sleeve gastrectomy has shown good results of excess weight loss, the high pressure system of a sleeve has shown mixed results or increased rate of GERD. The effects of SG on GERD symptoms is debated, with studies showing both improvement of GERD symptoms as well as worsening or even de novo development. Severe GERD following sleeve gastrectomy is a well-established complication. Preoperative predictors of severe reflux should be used to have an informed discussion with patients regarding their best options for primary bariatric surgical technique. Medical therapy remains the primary therapy in worsening or de novo GERD after sleeve gastrectomy; however, surgical techniques such as conversion to RYGB or MSA are safe and effective.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lundell L, Ruth M, Sandberg N, Bove-Nielsen M. Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sci. 1995;40(8):1632–5. https://doi.org/10.1007/BF02212682.
Anand G, Katz PO. Gastroesophageal reflux disease and obesity. Rev Gastroenterol Disord. 2008;8(4):233–9.
Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis. 2004;22(2):108–14. https://doi.org/10.1159/000080308.
Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett’s esophagus. Gastroenterology. 2007;133(2):403–11. https://doi.org/10.1053/j.gastro.2007.05.026.
Lagergren J, Bergström R, Nyrén O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130(11):883–90. https://doi.org/10.7326/0003-4819-130-11-199906010-00003.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211. https://doi.org/10.7326/0003-4819-143-3-200508020-00006.
Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin N Am. 2014;43(1):161–73. https://doi.org/10.1016/j.gtc.2013.11.009.
Prachand VN, Alverdy JC. Gastroesophageal reflux disease and severe obesity: fundoplication or bariatric surgery? And severe obesity: causality or. World J Gastroenterol. 2010;16(30):3757–61. https://doi.org/10.3748/wjg.v16.i30.3757.
De Vries DR, Van Herwaarden MA, Smout AJPM, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol. 2008;103(6):1349–54. https://doi.org/10.1111/j.1572-0241.2008.01909.x.
Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 2015;21(36):10348–57. https://doi.org/10.3748/wjg.v21.i36.10348.
Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc. 2001;15(9):986–9. https://doi.org/10.1007/s004640000392.
Kellogg TA, Andrade R, Maddaus M, Slusarek B, Buchwald H, Ikramuddin S. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007; https://doi.org/10.1016/j.soard.2006.08.011.
Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network. Ann Surg. 2011;254(3):410–22. https://doi.org/10.1097/sla.0b013e31822c9dac.
DuPree CE, Blair K, Steele SR, Martin MJ. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a National Analysis LSG in GERD Patients LSG in GERD Patients. JAMA Surg. 2014;149(4):328–34. https://doi.org/10.1001/jamasurg.2013.4323.
Chiu S, Birch DW, Shi X, Sharma AM, Karmali S. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis. 2011;7(4):510–5. https://doi.org/10.1016/J.SOARD.2010.09.011.
Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16(11):1450–6. https://doi.org/10.1381/096089206778869933.
Oor JE, Roks DJ, Ünlü Ç, Hazebroek EJ. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016;211(1):250–67. https://doi.org/10.1016/J.AMJSURG.2015.05.031.
Daes J, Jimenez ME, Said N, Dennis R. Improvement of gastroesophageal reflux symptoms after standardized laparoscopic sleeve gastrectomy. Obes Surg. 2014;24(4):536–40. https://doi.org/10.1007/s11695-013-1117-6.
Sharma A, Aggarwal S, Ahuja V, Bal C. Evaluation of gastroesophageal reflux before and after sleeve gastrectomy using symptom scoring, scintigraphy, and endoscopy. Surg Obes Relat Dis. 2014;10(4):600–5. https://doi.org/10.1016/J.SOARD.2014.01.017.
Rebecchi F, Allaix ME, Patti MG, Schlottmann F, Morino M. Gastroesophageal reflux disease and morbid obesity: to sleeve or not to sleeve? World J Gastroenterol. 2017;23(13):2269–75. https://doi.org/10.3748/wjg.v23.i13.2269.
Naik RD, Choksi YA, Vaezi MF. Impact of weight loss surgery on esophageal physiology. Gastroenterol Hepatol (N Y). 2015;11(12):801–9.
Lee W-J. Gastro esophageal reflux disease after sleeve gastrectomy: a real issue and future perspectives OPEN ACCESS. Am J Gen GI Surg. 2018;1(1):1–7.
Doulami G, Triantafyllou S, Natoudi M, et al. GERD-related questionnaires and obese population: can they really reflect the severity of the disease and the impact of GERD on quality of patients’ life? Obes Surg. 2015;25(10):1882–5. https://doi.org/10.1007/s11695-015-1614-x.
Althuwaini S, Bamehriz F, Aldohayan A, et al. Prevalence and predictors of gastroesophageal reflux disease after laparoscopic sleeve gastrectomy. Obes Surg. 2018;28(4):916–22. https://doi.org/10.1007/s11695-017-2971-4.
Gagner M, Hutchinson C, Rosenthal R. Fifth international consensus conference: current status of sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(4):750–6. https://doi.org/10.1016/J.SOARD.2016.01.022.
Parmar CD, Mahawar KK, Boyle M, Schroeder N, Balupuri S, Small PK. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass is effective for gastro-Oesophageal reflux disease but not for further weight loss. Obes Surg. 2017;27(7):1651–8. https://doi.org/10.1007/s11695-017-2542-8.
Quezada N, Hernández J, Pérez G, Gabrielli M, Raddatz A, Crovari F. Laparoscopic sleeve gastrectomy conversion to Roux-en-Y gastric bypass: experience in 50 patients after 1 to 3 years of follow-up. Surg Obes Relat Dis. 2016;12(8):1611–5. https://doi.org/10.1016/J.SOARD.2016.05.025.
Broderick RC, Smith CD, Cheverie JN, et al. Magnetic sphincter augmentation: a viable rescue therapy for symptomatic reflux following bariatric surgery. Surg Endosc. 2019; https://doi.org/10.1007/s00464-019-07096-z.
Crawford C, Gibbens K, Lomelin D, Krause C, Simorov A, Oleynikov D. Sleeve gastrectomy and anti-reflux procedures. Surg Endosc. 2017;31(3):1012–21. https://doi.org/10.1007/s00464-016-5092-6.
Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol. 2014;20(24):7730–8. https://doi.org/10.3748/wjg.v20.i24.7730.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Flynn, S.M., Broderick, R.C. (2020). Gastroesophageal Reflux Disease in Sleeve Gastrectomy: Pathophysiology and Available Treatments. In: Horgan, S., Fuchs, KH. (eds) Management of Gastroesophageal Reflux Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-48009-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-48009-7_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-48008-0
Online ISBN: 978-3-030-48009-7
eBook Packages: MedicineMedicine (R0)